Date published: 2026-2-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

PAF C-16 (CAS 74389-68-7)

5.0(1)
Write a reviewAsk a question

See product citations (10)

Alternate Names:
3-sn-Phosphatidylcholine, 1-hexadecyl-2-acetyl; Platelet activating factor C 16;1-O-hexadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine
Application:
PAF C-16 is a PAF-R, MAP kinase, and MAP kinase kinase activator
CAS Number:
74389-68-7
Purity:
≥98%
Molecular Weight:
523.7
Molecular Formula:
C26H54NO7P
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

PAF C-16 is a PAF-R (platelet activating factor receptor) activator and ligand for PAF-R with a C16 alkane group. It also acts as an extracellular signaling lipid. PAF C-16 may act to increase vascular permeability and thus induce inflammation. Additionally, it has been reported to activate MAP kinase (MAPK) and MEK (MAP kinase kinase, MAPKK) in CHO cells.


PAF C-16 (CAS 74389-68-7) References

  1. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.  |  Kassuya, CA., et al. 2006. Eur J Pharmacol. 546: 182-8. PMID: 16925995
  2. Small bowel injury associated to allergy is triggered by platelet-activating factor, mast cells, neutrophils and protected by nitric oxide.  |  Kwasniewski, FH., et al. 2008. Int Immunopharmacol. 8: 371-8. PMID: 18182253
  3. The role of ET(A) and ET(B) receptor antagonists in acute and allergic inflammation in mice.  |  Kassuya, CA., et al. 2008. Peptides. 29: 1329-37. PMID: 18632188
  4. Platelet-activating factor.  |  Prescott, SM., et al. 1990. J Biol Chem. 265: 17381-4. PMID: 2170377
  5. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8.  |  Grob, PM., et al. 1990. J Biol Chem. 265: 8311-6. PMID: 2186041
  6. Interleukin-6 production by tumor necrosis factor and lipopolysaccharide-stimulated rat renal cells.  |  Pirotzky, E., et al. 1990. Clin Immunol Immunopathol. 56: 271-9. PMID: 2199100
  7. [Serum metabolomics analysis on benign prostate hyperplasia in mice based on liquid chromatography-mass spectrometry].  |  Geng, Y., et al. 2014. Se Pu. 32: 1301-5. PMID: 25902635
  8. Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection.  |  Hergott, CB., et al. 2015. J Clin Invest. 125: 3878-90. PMID: 26426079
  9. Platelet activating factor; chemical and biochemical characteristics.  |  Hanahan, DJ. and Kumar, R. 1987. Prog Lipid Res. 26: 1-28. PMID: 3313430
  10. Egg components reverse the atrophy induced by injury in skeletal muscles.  |  Sawano, S., et al. 2022. Genes Cells. 27: 138-144. PMID: 34929062
  11. High-Content Imaging Platform to Discover Chemical Modulators of Plasma Membrane Rafts.  |  Fricke, N., et al. 2022. ACS Cent Sci. 8: 370-378. PMID: 35355811
  12. Comparative Metabolomics and Lipidomics of Four Juvenoids Application to Scylla paramamosain Hepatopancreas: Implications of Lipid Metabolism During Ovarian Maturation.  |  Fu, Y., et al. 2022. Front Endocrinol (Lausanne). 13: 886351. PMID: 35574001
  13. Characteristics of 1-O-hexadecyl- and 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine-stimulated granule enzyme release from human neutrophils.  |  Smith, RJ., et al. 1983. Clin Immunol Immunopathol. 28: 13-28. PMID: 6872358
  14. Blood cardiolipin in haemodialysis patients. Its implication in the biological action of platelet-activating factor.  |  Antonopoulou, S., et al. 1996. Int J Biochem Cell Biol. 28: 43-51. PMID: 8624843
  15. Guanine nucleotide regulatory proteins, Gq and Gi1/2, mediate platelet-activating factor-stimulated phosphoinositide metabolism in immortalized hippocampal cells.  |  Shi, LC., et al. 1996. J Neurochem. 67: 1478-84. PMID: 8858930

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PAF C-16, 5 mg

sc-201009
5 mg
$131.00

PAF C-16, 25 mg

sc-201009A
25 mg
$300.00